Effectiveness of Evodiamine and Evodone as Ovarian Anticancer In Silico

DOI

10.2991/snk-19.2019.4How to use a DOI?

Keywords

Evodiamine, Evodone Anticancer, Ovarian, in silico

Abstract

Cancer is a disease that is still a global problem which ranked second leading cause of death, amounting to 13% after cardiovascular disease. Cancer of the ovaries are the second most common group of gynecologic cancers, and account for about 5% of all women's cancers. Chemotherapy (chemo) is the use of drugs to treat cancer. Chemo can be useful to kill very small amounts of cancer cells that may still be around after surgery, for cancers that have metastasized (spread), or to shrink very large tumors to make surgery easier. Chemo drugs can cause side effects. These side effects usually go away after treatment is finished. Therapeutic herbs and their derivative phytocompounds are being progressively more accepted as useful complementary treatments for cancer. Zodia (Evodia sp) is Indonesian endemic plants containing some active compounds as anticancer there are evodiamine and evodone. In this study, we investigated the effectiveness of evodiamine and evodone by in silico method to threat ovarian cancer. This study uses Autodock, PyRx and LigPlot software with the method used is molecular docking. The docking results showed the effectiveness of the two compounds was assessed from binding affinity on evodiamine of -7 kcal / mol and RMSD (Root Mean Square Deviation) of 1.66 Å, while the evodone compound was -5.8 kcal / mol and 2.52 Å. From these results it can be proven that the evodiamine compound has the most effective results as an ovarian anticancer compound in silico.

Copyright

© 2019, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Erlix Rakhmad Purnama
AU  - Ghea Dionita Sanora
AU  - Elly Yana Mastura
AU  - Muhammad Ongky Muji Handoyo
PY  - 2019/12
DA  - 2019/12
TI  - Effectiveness of Evodiamine and Evodone as Ovarian Anticancer In Silico
BT  - Proceedings of the National Seminar on Chemistry 2019 (SNK-19)
PB  - Atlantis Press
SP  - 79
EP  - 81
SN  - 2590-3195
UR  - https://doi.org/10.2991/snk-19.2019.4
DO  - 10.2991/snk-19.2019.4
ID  - Purnama2019/12
ER  -